GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » RBC Bioscience Corp (ROCO:6848) » Definitions » Total Stockholders Equity

RBC Bioscience (ROCO:6848) Total Stockholders Equity : NT$240.7 Mil (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is RBC Bioscience Total Stockholders Equity?

RBC Bioscience's Total Stockholders Equity for the quarter that ended in Dec. 2023 was NT$240.7 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. RBC Bioscience's Book Value per Share for the quarter that ended in Dec. 2023 was NT$18.55. The ratio of a company's debt over equity can be used to measure how leveraged this company is. RBC Bioscience's Debt-to-Equity for the quarter that ended in Dec. 2023 was 2.02.

RBC Bioscience Total Stockholders Equity Historical Data

The historical data trend for RBC Bioscience's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

RBC Bioscience Total Stockholders Equity Chart

RBC Bioscience Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Stockholders Equity
Get a 7-Day Free Trial 87.73 174.73 256.83 248.81 240.71

RBC Bioscience Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only 256.83 253.55 248.81 236.59 240.71

RBC Bioscience  (ROCO:6848) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

RBC Bioscience's Book Value per Share for the quarter that ended in Dec. 2023 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(240.709-0)/12.976
=18.55

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

RBC Bioscience's Debt-to-Equity for the quarter that ended in Dec. 2023 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(74.764 + 412.598) / 240.709
=2.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

RBC Bioscience Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of RBC Bioscience's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

RBC Bioscience (ROCO:6848) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » RBC Bioscience Corp (ROCO:6848) » Definitions » Total Stockholders Equity
Comparable Companies
ROCO:4197 ROCO:6744 ROCO:6864 ROCO:6662 ROCO:4131 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX SZSE:300122 BGNE ALNY OCSE:GMAB BMRN
Traded in Other Exchanges
N/A
Address
Lane 235, Baoqiao Road, 3rd Floor, No. 132, New Taipei City, TWN, 23145
Website
https://www.rbcbioscience.com
RBC Bioscience Corp is a bio sciences company. Its products include Real Genomics, MagCore Automated Nucleic Acid Extractor, and MagCore Nucleic Acid Extraction KIT.

RBC Bioscience (ROCO:6848) Headlines

No Headlines